Popular traded US stocks on POEMS in August 2021

Popular traded US stocks on POEMS in August 2021

The following lists some of the more popular stocks – not in any order of ranking – traded by POEMS clients along with major stock announcements in the month of August.

At a glance:

  • After moving down sharply, all three major indices trended higher in the second half of the month, to record highs.
  • US infrastructure package has been approved. The Fed said tapering could start this year.

All three US major indices – Dow Jones, S&P 500 and Nasdaq Composite – traded higher to record levels in August. In the middle of the month, all three indices had dipped on the back of fears of the COVID-19 Delta variant and a 1.1% fall in retail sales, which was worse than the -0.3% expected.

S&P 500 Nasdaq Dow Jones
Month opening 4,406.86 points 14,758.60 points 34,968.56 points
Highest before dip 4,479.72 points
(+1.65%)
15,184.27 points
(+2.88%)
35,631.83 points
(+1.89%)
Lowest after dip 4,382.44 points
(-0.55%)
14,423.16 points
(-2.27%)
34,960.25 points
(-0.02%)
Month-close 4,552.69 points
(+3.31%)
15,259.24 points
(+3.40%)
35,360.74 points
(+1.12%)

Percentage gains were calculated from month openings

The month marked an important milestone for the S&P 500 as it doubled from its pandemic low of 2,237.40.

Popular traded US stocks on POEMS in August 2021

 

 

All three indices managed to close higher despite the setbacks, suggesting market confidence.

Biden’ long-awaited infrastructure package was approved, though the budget was short of his March 202 proposal by US$2.3tn. The money will be used to upgrade roads, bridges, tunnels, airports, rail networks and the power grid. Americans’ access to broadband and clean drinking water will also be improved. As the package will widen the US’ national budget deficit by US$256bn, several measures will have to be taken to fund it. About US$200bn of unspent COVID-19 relief money that was intended for unemployment insurance will likely be used. A tax on cryptocurrencies[2] is also being considered.

The annual Jackson Hole Symposium took place late in the month, causing the three indices to rebound from their previous bearish lows. On the first day of the symposium, Nasdaq gained 0.83%, S&P gained 0.81% while the Dow recovered the least, by 0.64%. Jay Jerome.

Powell signalled that the Fed could start tapering this year when inflation reaches around 2% and substantial progress has been made towards maximum employment. Powell is still confident that inflation is transitory, with the higher prices coming from sectors that were badly hit by the pandemic.

Additionally, the Fed says any decision to raise rates will not be affected by tapering, although the requirements for raising interest rates are similar to those for tapering, with the added requirement of inflation being on track to exceed 2% for some time.

The Fed is being careful with monetary tightening as it is worried of unnecessarily roiling markets. If tightening is premature, there might be a repeat of the taper tantrum in 2013 when Treasury yields spiked, triggering volatility and sell-offs in the market.

As usual, we have included technical charts for our 10 counters. The charts are for your information only and the support and resistance levels discussed are solely based on our dealers’ views. They should not be construed as buy or sell recommendations and investors/traders are advised to exercise their own due diligence before making any trade.

Amazon (NYSE: AMZN)

Share price of the largest e-commerce player by revenue dropped after earnings were announced in August. It dropped by 5.28%, from an opening price of US$3,353.10 to a low of US$3,175.76.

Q2 EPS was US$15.12, 46.79% higher than Q2 2020’s US$10.30. Net income was US$7.8bn, 50% higher than Q2 2020’s US$5.2bn.[3] The increase could be explained by consumers flocking to online shopping while taking shelter at home. But as the pandemic wanes, quarantines will be lifted and consumers will be able to shop more conveniently in malls. This may lead to slower growth in Q3 for Amazon.[4]

Amazon Web Services, which accounts for 54% of the company’s operating income, announced a partnership with Dish Network to build out cloud-based 5G infrastructure. It said it would open data centres in Israel and the UAE. These will enable Amazon to serve end-users in the Middle East, providing room for further growth even if its e-commerce business slows down.

Popular traded US stocks on POEMS in August 2021

 

Source: POEMS
 

Technical analysis:

Status: Neutral
Support: US$3,369.53
Resistance: US$3,497.51
Immediate resistance must be broken for more upside

Sea Limited (NYSE: SE)

Sea is a Singapore-based consumer Internet company that operates Garena, Shopee and SeaMoney. It surged up to a new high of US$344.77, up 23.22% from its month opening of US$279.80. The increase could be largely attributed to the company’s high revenue growth.

Sea reported an adjusted loss per share of 61 cents on revenue of US$2.28bn. Analysts had expected an adjusted loss per share of 49 cents on revenue of US$2.06bn,[5] with a net loss of US$433.7mn, 10.21% more than the US$393.5mn in Q2 2020.[6] Revenue, however, grew to US$2.3bn in Q2, 160% more than the previous year’s US$882mn. The increase in net loss despite higher revenue was due to a 126.6% jump in operating expenses, from US$573.6mn to US$1.3bn. The money was mostly spent on sales and marketing as the company aggressively chased after market share for potentially even higher revenue growth in the near future.

Sea raised its guidance for both digital entertainment and e-commerce. Digital entertainment bookings are expected to be between US$4.5bn and US$4.7bn while e-commerce revenue is expected to be between US$4.7bn and US$4.9bn in 2021. This could cover Sea’s high operating expenses. Based on the guidance, analysts believe that the company will post a final loss in 2021 before a turnaround to profits in 2022.[7]

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Bullish market structure
Support: US$321.60
Resistance: US$349.22
Immediate resistance must be broken for more upside

Vaxart Inc (NASDAQ: VXRT)

Vaxart is an American biotech vaccine developer. It announced that Julie M. Cherrington is joining its board of directors[8]. Julie M. Cherrington is experienced in biological sciences and well-versed in the transfer of drugs from the development process to commercialisation.

Dr. Cherrington is seen as a great asset to Vaxart, which is preparing to start Phase II trials of COVID-19 oral pills. Oral pills hold promise as existing injected vaccines need to be transported using cold chain logistics[9], which is still lacking in some areas.

Transportation difficulties coupled with the emergence of the more contagious Delta variant and vaccination hesitancy[10] indicate that the pandemic could be around for a while. With the pandemic not subsiding anytime soon, having pills can help countries gain herd immunity, especially in areas with poor accessibility. Vaxart’s lowest trading price during the month was US$7.61 while its highest was US$10.33.

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$8.51
Resistance: US$9.46
Range-bound

Advanced Micro Devices (NASDAQ: AMD)

AMD, a global company that designs and develops semiconductor devices used in computer processing, went on a bull run for six days after releasing earnings. It hit an all-time high of US$122.49, up 15.62% from its month opening of US$105.93.

Q2 2021 revenue was US$3.85bn, 99% higher than Q2 2020’s US$1.932bn. Net income was US$778mn, 260% higher than Q2 2020’s US$216mn. This led to an EPS of US$0.63, 250% higher than Q2 2020’s US$0.18.

AMD expects 2021 revenue to rise 60% YoY, on the basis that Tesla (NASDAQ: TSLA) will be using its processors and GPUs for its new Tesla Model S and X vehicles. AMD also shared that more than 40 game developers have pledged to support its FidelityFX Super Resolution.[11]

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$103.87
Resistance: US$112.41
Range-bound

Ocugen Inc (NASDAQ: OCGN)

 

Ocugen is a biopharmaceutical company focusing on curing blindness. Its share price touched a month-high of US$9.35 and also a low of US$6.68. The company has partnered Bharat Biotech to create a COVID-19 vaccine called Covaxin.

The development of this vaccine caused an issue for the company . Ocugen had released an announcement in February 2021, which caused a huge spike in its share price to US$18.77. The announcement was subsequently deemed misleading as Ocugen’s application to the FDA had failed to include sufficient data to support an emergency use authorisation. The stock was sold down, which caused investors who suffered losses to file a lawsuit against the company for damages. Its shares are now trading at around US$7. Investors have to ponder whether its share price has factored in the worst.

As of now, Covaxin is under review for emergency use in Canada.[14]

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$6.98
Resistance: US$9.02
Range-bound

Robinhood Markets (NASDAQ: HOOD)

Robinhood is a US fintech company with 31mn users. It offers commission-free trading and various financial products for investment. Revenue is earned from order flows and premium membership fees.

Robinhood got listed on the Nasdaq on 29 July 2021 at US38.[15] It closed at US$34.82 on its debut, reflecting investors’ hesitance over possible regulatory scrutiny.[16] Share price subsequently went on a bull charge for four days, hitting a high of US$85. This was up 123.7% from its opening price of US$38, possibly due to Ark Invest’s – Cathie Wood – purchase of 3.15mn shares worth US$147.5mn.[17]

Shortly after, its share price fell as the company reported a net loss of US$502mn. It also warned investors that its Q3 results could be affected by a slowdown in trading after a record Q2. Early investors also started to take profits. These included a number of venture capital firms such as Andreessen Horowitz and New Enterprise Associates. Filing to sell up to 97,876,033 shares, they contributed to a 47.86% drop in Robinhood from its month high to a closing price of US$44.32.[18]

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$33.24
Resistance: US$50.56
Range-bound

QuantumScape (NYSE: QS)

QuantumScape is a battery start-up backed by Bill Gates and Volkswagen. It has a vision to extend battery ranges to support fast charging and lower costs[19]. The stock is trading at around US$21, down from its all-time high of US$114.7.

QuantumScape’s prototype batteries will be delivered in 2022. CEO Jagdeep Singh said the company recently managed to produce a 10-layer battery cell which will help improve battery performance to a level of parity with combustion engines. This breakthrough has given Singh the confidence that the company could commercialise the batteries by 2025.

That said, there is no way investors are able to test the claims, given the secrecy surrounding the battery-development industry. According to an analysis by Seeking Alpha[20], the batteries were not tested out of the lab and are currently still the size of an iWatch battery. This indicates they are still far from commercialisation, requiring lots of funding for research and development. Which means QuantumScape is unlikely to be profitable in the mid-term.

Once commercialised, Volkswagen will be able to source from QuantumScape the batteries it needs for its electric vehicles. QuantumScape will be able to tap the experience of Bill Gates and Volkswagen to stride towards its goals.

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$21.51
Resistance: US$24.52
Range-bound

Palantir Technologies (NYSE: PLTR)

Palantir is an American software company specialising in big data analytics. It released its Q2 earnings on 12 August 2021. Revenue grew 49% YoY to US$376mn, beating estimates of US$352.3mn. Twenty net new customers were added, translating to a 13% increase in total customers QoQ.

Palantir expects Q3 revenue to be around US$385mn and annual revenue growth of 30% or more through 2025 [21]. It is reducing its reliance on contracts from the government, by wooing commercial customers through subscription-based data gathering and analytics technologies. This could diversify its revenue streams.

One area that has drawn scrutiny is Palantir’s increased investments in special purpose acquisition companies or SPACs. Palantir is seen as using these vehicles to win business from emerging companies that can benefit from its big data analytics software[22], in other words acquiring revenue the easy way.

Shortly after its earnings announcement, Cathie Wood’s active funds bought US$139mn worth of Palantir shares[23]. This was on the back of its buoyant sales forecasts. Its share price leapt by 20.22% from its opening price of US$21.91 to close at US$26.34.

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Bullish market structure
Support: US$25.36
Resistance: US$26.95
Immediate resistance has to be broken for more upside

AMC Entertainment Holdings Inc (NYSE: AMC)

The largest cinema chain in the US, AMC Entertainment, reported better-than-expected Q2 earnings. Revenue of US$444.7mn and a net loss of 71 cents a share beat market expectations of US$382mn and loss per share of US$1.42. AMC reached a high of US$48.30 and a low of US$28.91.

A few other things were also announced by AMC during the month. One was its acceptance of bitcoins[24] in the US by year-end, citing increasing enthusiasm on cryptocurrencies. AMC will also start accepting Apple Pay and Google Pay. However, it did not specify how bitcoins would be used for payment. Additionally, AMC is adding new theaters in three locations: two in LA, two in Chicago and one in Atlanta[25]. This is in preparation for a return to cinemas by movie goers.

AMC traded sharply higher on 24 August 2021, opening at US$37.19 and closing at US$44.26. The reason for the spike was increased discussions on Reddit’s forum and AMC’s trending to social media[26]. This suggests that AMC is still highly driven by speculation and investors have to be wary.

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$31.26
Resistance: US$46.61
Range-bound

Naked Brand Group (NASDAQ: NAKD)

A meme stock, Naked Brand is an apparel and swimwear company based in Australia. At the beginning of the year, it leveraged its higher share price to sell shares, raising cash to repay debts and acquire businesses[27]. In August, its shares troughed at US$0.50 and peaked at US$0.698, a far cry from its IPO price of US$1.70 in January 2021[28]. This reflected a short squeeze on its stock following a meme-stock rally in January 2021.

Naked Brand has lost no time in acquiring a company, though no details have been revealed[29]. The reason for its rush is its potential delisting from Nasdaq in October 2021. Naked Brand has received notification from Nasdaq[30] “that the minimum bid price for the Company’s ordinary shares was below $1.00 per share for a period of 30 consecutive business days”, which is against its listing rules. If removed, its shares will trade over the counter. The company will have to ensure that its stock is able to trade at least at US$1.00 for a minimum of 10 consecutive days to remain listed.

If management is able to prove that its acquisition can add synergies to the group, this may also save Naked Brand from a delisting. Its Nasdaq fate now appears to hinge on an outcome of the acquisition.

Popular traded US stocks on POEMS in August 2021

 

 

Technical analysis:
Status: Neutral
Support: US$0.585
Resistance: US$0.77
Range-bound

Bloomberg analysts’ recommendations

The table below shows the consensus ratings and average ratings of all analysts updated on Bloomberg in the last 12 months. Consensus ratings have been computed by standardising analysts’ ratings to a scale of 1 (Strong Sell) to 5 (Strong Buy). The table also shows the number of analysts’ recommendations to buy, hold or sell the stocks as well as their average target prices.

Security Consensus Rating BUY HOLD SELL Target Price (US$)
Amazon (NYSE: AMZN) 4.96 55(100%) 0(0%) 0(0%) 4156.52
Sea Limited (NYSE: SE) 4.85 25(96.2%) 1(3.8%) 0(0%) 360.05
Vaxart Inc (NASDAQ: VXRT) 4.5 3(75%) 1(25%) 0(0%) 12.5
Advanced Micro Devices (NASDAQ: AMD) 4.05 25(58.1%) 16(37.2%) 2(4.7%) 111.77
Ocugen Inc (NASDAQ: OCGN) 3.8 2(40%) 3(60%) 0(0%) 7.28
Robinhood Markets (NASDAQ: HOOD) 3.79 7(50%) 6(42.9%) 1(7.1%) 54.08
QuantumScape (NYSE: QS) 3.29 2(28.6%) 4(57.1%) 1(14.3%) 36.33
Palantir Technologies(NYSE: PLTR) 2.75 2(25%) 3(37.5%) 3(37.5%) 24.67
AMC Entertainment Holdings Inc (NYSE: AMC) 1.89 0(0%) 4(44.4%) 5(55.6%) 5.44
Naked Brand Group (NASDAQ: NAKD)

 

To round up

In general, investors are advised to be cautious with meme stocks as they are fundamentally overpriced. Compared to meme stocks, growth stocks such as AMZN.US still have some slack to the Bloomberg analysts’ target prices. Based on the recent Jackson Hole Symposium, monetary policy should not tighten so soon. As such, the interest-rate-sensitive tech sector should continue to grow. Non-farm payroll data came in worse than expected, at 235,000 in September 2021 vs expectations of 720,000. This justifies the Fed’s view that more work has to be done on the employment side before scaling back on monetary policy.

The next major market event is the FOMC meeting on 21-22 September. The meeting may provide better clarity on US monetary policy. Markets are expected to be relatively muted before that.

Click here to learn more about trading stocks in the US

Click here to open a POEMS trading account

Reference:

Disclaimer
Important Information: This report is prepared and/or distributed by Phillip Securities Research Pte Ltd (“Phillip Securities Research”), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgement. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSES Where the report contains research analyses or reports from a foreign research house, please note: (i) recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and (ii) to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.

If Distribution is to Australian Investors This report is produced by Phillip Securities Pte Ltd and is being distributed in Australia by Phillip Capital Limited (Australian Financial Services License No. 246827). This report contains general securities advice and does not take into account your personal objectives, situation and needs. Past performance is not a reliable indicator of future performance. Please read the Disclosures and Disclaimers set out above. By receiving or reading this report, you agree to be bound by the terms and limitations set out above. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.